1. Home
  2. Knowledge Base
  3. References
  4. Depleting syndecan-4+ T lymphocytes using toxin-bearing dendritic cell-associated heparan sulfate proteoglycan-dependent integrin ligand: A new opportunity for treating activated T cell-driven disease.

Depleting syndecan-4+ T lymphocytes using toxin-bearing dendritic cell-associated heparan sulfate proteoglycan-dependent integrin ligand: A new opportunity for treating activated T cell-driven disease.

Akiyoshi H, Chung JS, Tomihari M, Cruz PD, Jr., Ariizumi K (2010) Depleting syndecan-4+ T lymphocytes using toxin-bearing dendritic cell-associated heparan sulfate proteoglycan-dependent integrin ligand: A new opportunity for treating activated T cell-driven disease. J Immunol 184:3554-3561. doi: 10.4049/jimmunol.0903250

Summary: The dendritic cell-associated heparin sulfate proteoglycan-dependent integrin ligand (DC-HIL) exclusively associates with syndecan-4 (SD-4), which is expressed on some activated T cells. The authors biotinylated DC-HIL and combined it with streptavidin-ZAP (Cat. #IT-27). This complex was then applied to resting or activated T cells in culture at a concentration of 10 µg/ml. Only activated T cells were bound and eliminated.

Related Products: Streptavidin-ZAP (Cat. #IT-27)

Read the featured article in Targeting Trends.